Related Experiment Videos
Prognosis of primary malignant melanomas
The Journal of Dermatologic Surgery and Oncology
|February 1, 1979
Summary
Patients with primary malignant melanoma without metastasis have a high survival rate. Five-year survival is 75-80%, and ten-year survival is 55-65%, irrespective of treatment skill.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Malignant melanoma is a significant skin cancer.
- Prognosis for melanoma patients varies widely.
- Accurate prognostic factors are crucial for patient management.
Purpose of the Study:
- To determine the long-term survival rates for primary malignant melanoma patients.
- To assess the impact of prognostic factors on survival.
- To evaluate the curability of malignant melanoma.
Main Methods:
- Retrospective analysis of primary malignant melanoma cases.
- Inclusion of patients without clinical or radiological evidence of metastasis.
- Statistical analysis of survival data (5-year and 10-year).
Main Results:
- Patients with primary malignant melanoma and no detectable metastases have a 75-80% five-year survival rate.
- Ten-year survival rates for this group range from 55-65%.
- Survival rates appear independent of other prognostic factors and surgical skill.
Conclusions:
- Primary malignant melanoma without metastasis has a generally favorable prognosis.
- The absolute curability of malignant melanoma remains undetermined.
- Further research is needed to establish definitive cure criteria.